
The Conversation: André Hoffmann, vice-chairman and board member and Dr. Jörg Duschmalé, board member, Roche
Roche's founding family members on the future of healthcare and the family professional relationship.
Roche's founding family members on the future of healthcare and the family professional relationship.
The two medicines prescribed together is a standard treatment regimen approved in over 100 countries for both early and metastatic HER2-positive breast cancer.